Navigation Links
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research

hwestern Medical School, will make on oral presentation on April 1 titled "ACP-104 Novel Atypical Antipsychotic with Potential Cognitive Effects." During the presentation, Dr. Tamminga will review the unique preclinical properties of ACP-104 as well as top-line clinical results from the single ascending-dose and multiple ascending-dose studies with ACP-104, which were announced in July 2006. Additionally, data from the single ascending-dose study will be presented in a poster titled "ACP-104 Safety and Pharmacokinetics in Psychosis."

ACP-104: Demonstrates Pro-Cognitive Actions in Experimental Models

In a poster presentation titled "N-Desmethylclozapine Demonstrates Pro-Cognitive Actions in Experimental Models," ACADIA researchers describe preclinical data that indicate ACP-104, in addition to being active in models predictive of antipsychotic activity, has a superior profile in animal models of cognitive function. ACP-104 showed an improved performance in the Radial Arm Maze and no adverse effect in the Novel Object Recognition assay. In contrast, clozapine impaired performance in both these assays. The pro-cognitive effects of ACP-104 were shown to be dependent upon M1 muscarinic activity. These findings suggest that ACP-104 will have a superior clinical profile with activity against all symptom domains (positive, negative, and cognitive) in schizophrenia.

ACP-104: Unique Receptor Profile for Treating Psychosis

In a poster presentation titled "Comparison of the In Vitro Pharmacology of N-Desmethylclozapine (ACP-104) with other Atypical Antipsychotic Agents," ACADIA researchers describe experiments that used cell based assays to characterize the functional interaction of ACP-104 and other antipsychotic drugs with a number of receptors implicated in the efficacy or adverse effects of antipsychotic drugs. The results demonstrated that ACP-104 has a receptor profile that is distinct from and potentially advantageous to clozapine and other at
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Faust Pharmaceuticals Phase IIa Results for Parkinsons Disease Presented at International Congress of Parkinsons Disease and Movement Disorders
2. Data from Rexahn Pharmaceuticals Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago
3. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
4. Aeolus Pharmaceuticals AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
5. Aeolus Pharmaceuticals AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
8. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
9. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
10. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
11. New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
Post Your Comments:
(Date:7/22/2014)... 2014 Elekta (NSE:EKTAb) and Royal Philips ... NHS Foundation Trust ( Manchester, UK ), ... mission is to develop the clinical value of an ... Such a system would, in principle, improve the practice ... "The Christie was an essential participant in ...
(Date:7/22/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that the U.S. Food and Drug Administration, ... IND, application.  Such clearance will permit Galmed to conduct ... the United States for the treatment ...
(Date:7/22/2014)... EVANSTON, Ill. , July 22, 2014 /PRNewswire/ ... access to physicians is spreading to previously rep-friendly ... from global sales and marketing consulting firm ZS ... from more than 200 U.S. pharmaceutical sales teams. ... and other prescribers meet with the pharmaceutical sales ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5
... June 13 , - Lack of Physician Education May ... patients and physicians shows that,fibromyalgia, a chronic widespread pain condition, ... on patients often resulting in an,inability to work and earn ... fact that in most countries it takes patients on,average, 1.9 ...
... On Friday, Inspire,Pharmaceuticals (Nasdaq: ISPH ) announced ... with denufosol tetrasodium inhalation solution,delivered via PARI,s LC ... of cystic fibrosis (CF)., "We are pleased ... that,Inspire,s denufosol tetrasodium inhalation solution delivered via PARI,s ...
Cached Medicine Technology:New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact 2New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact 3New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact 4Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results 2
(Date:7/23/2014)... Wisconsin (PRWEB) July 23, 2014 QueenBeeTickets.com is ... which is a coup for rock music fans who are ... online ticket buyers visit the site, they can use promo ... Click Here to view the inventory of discounted ... U.S. cities in August, September and October, with The Eagles ...
(Date:7/23/2014)... 23, 2014 There is inherently nothing ... that it is healthy enough to react to specific ... “washing out” harmful toxins and bacteria from the body ... body just cannot do. , However, the social ... commonly known as “excessive sweating”—are serious: since sweating itself ...
(Date:7/23/2014)... Online medical service provider MeMD has appointed ... Dr. Lorenzo joins the MeMD executive team with over ... a part of this remote treatment model, telemedicine. This is ... in medical school, that someday we could treat people across ... here and it hasn't been that long,” says Dr. Lorenzo. ...
(Date:7/23/2014)... 23, 2014 Once viewed with suspicion ... hospice has become a $14 billion-a-year business and arguably ... In Changing the Way We Die , award-winning ... means to today’s aging population and their families. It’s ... the hospice landscape, reporting the stories of patients, caregivers ...
(Date:7/23/2014)... Picnic Lunches, Residents of The Clare can now ... festivals, while still dining on the fabulous cuisine of Chef ... park or to the beach or museum and we love ... they’re out,” said Brian Hughes, director of dining services for ... just loving.” , Hagopian, the executive chef of The Clare ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:Dealing with Loss: Library Journal Calls Changing the Way We Die an Essential Read 2Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2
... A team of experts criticized Food and Drug Administration ... safety of new drugs and take action promptly for ... will strengthen the discussion on the safety of the ... supervision. A serious discussion began in September 2004 when ...
... in the September issue of Alzheimer’s Disease and ... Florida’s Louis de la Parte Florida Mental Health// ... Policy and the School of Aging Studies report ... (ChE-Is) may delay placement into nursing homes and ...
... revive the thorny issue of making a one-year rural stint ... ,A proposal on the issue would be drafted ... reporters after the second meeting of the ministerial steering group ... December we hope to go to the cabinet for clearance ...
... United Kingdom is being nudged by a Swiss organization to ... that it can be considered for patients// suffering chronic mental ... Ludwig Minelli at the helm, is petitioning the Swiss Supreme ... "The question for politicians in Britain today is why do ...
... deterioration of Hong Kong’s air quality has resulted in increasing ... ,The deterioration of Hong Kong’s air quality has ... breathing problems. , , ,Researchers at Hong ... as sulphur dioxide, nitrogen dioxide and ozone of about three ...
... limit to the curiosity of researchers to unravel the potential ... to the origin of response to// fear, is a specific ... at the end of the tunnel for those in the ... ,Scientists used a fairly easy examination along with magnetic resonance ...
Cached Medicine News:Health News:Appraisal of FDA’s Drug Safety Proces 2Health News:Appraisal of FDA’s Drug Safety Proces 3Health News:Drug May Delay Nursing Home Placement for Dementia Patients 2Health News:Compulsory Rural Stint for Doctors: Ramadoss 2Health News:Fearful or Fearless, Control Exists in The Brain 2
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... The remote vision controls all ... chart projector from the wireless ... autorefraction measurements can be loaded ... wireless data transfer. The illuminated ...
... ultimate in clinical color vision tests. It ... red/green or blue/yellow color vision losses that ... from Plaquenil, for example), early optic neuritis, ... it is fast and accurate in quantifying ...
Medicine Products: